1. Home
  2. CIB vs BBIO Comparison

CIB vs BBIO Comparison

Compare CIB & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BanColombia S.A.

CIB

BanColombia S.A.

HOLD

Current Price

$65.18

Market Cap

14.5B

Sector

Finance

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$75.77

Market Cap

14.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIB
BBIO
Founded
1945
2015
Country
Colombia
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
14.7B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
CIB
BBIO
Price
$65.18
$75.77
Analyst Decision
Hold
Strong Buy
Analyst Count
5
21
Target Price
$47.75
$76.24
AVG Volume (30 Days)
295.3K
1.8M
Earning Date
11-06-2025
10-29-2025
Dividend Yield
7.44%
N/A
EPS Growth
22.14
N/A
EPS
1.96
N/A
Revenue
$6,289,868,892.00
$353,780,000.00
Revenue This Year
$33.27
$127.64
Revenue Next Year
$7.26
$78.38
P/E Ratio
$8.97
N/A
Revenue Growth
15.25
62.46
52 Week Low
$31.19
$27.23
52 Week High
$65.73
$78.44

Technical Indicators

Market Signals
Indicator
CIB
BBIO
Relative Strength Index (RSI) 64.14 62.87
Support Level $62.30 $75.82
Resistance Level $63.39 $78.44
Average True Range (ATR) 1.37 2.20
MACD -0.02 -0.24
Stochastic Oscillator 87.50 68.91

Price Performance

Historical Comparison
CIB
BBIO

About CIB BanColombia S.A.

Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: